NDC 63323-751-03 - Phenylephrine Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-751
- Requested NDC
- 63323-751-03
- Package NDCs from labels
- 63323-751-05, 63323-751-10, 63323-751-00, 63323-751-01, 63323-751-03, 63323-751-13
- Manufacturer
- Fresenius Kabi USA, LLC
- Effective date
- 2026-10-20
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Phenylephrine Hydrochloride - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2026-10-20 | HUMAN PRESCRIPTION DRUG LABEL |
| Phenylephrine Hydrochloride - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2025-05-15 | HUMAN PRESCRIPTION DRUG LABEL |
| PHENYLEPHRINE HYDROCHLORIDE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-02-22 | HUMAN PRESCRIPTION DRUG LABEL |
| Phenylephrine Hydrochloride - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2023-12-11 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-751-00 | Phenylephrine Hydrochloride | 1 mL in 1 VIAL, SINGLE-DOSE | INJECTION | 1 | 8 | |
| 63323-751-01 | Phenylephrine Hydrochloride | 25 in 1 CARTON | INJECTION | 25 | 8 | |
| 63323-751-05 | Phenylephrine Hydrochloride | 5 mL in 1 VIAL, PHARMACY BULK PACKAGE | INJECTION | 5 | 4 | |
| 63323-751-05 | Phenylephrine Hydrochloride | 1 in 1 CARTON | INJECTION | 1 | 4 | |
| 63323-751-10 | Phenylephrine Hydrochloride | 10 mL in 1 VIAL, PHARMACY BULK PACKAGE | INJECTION | 10 | 4 | |
| 63323-751-10 | Phenylephrine Hydrochloride | 1 in 1 CARTON | INJECTION | 1 | 4 | |
| 63323-751-03 | Phenylephrine Hydrochloride | 1 mL in 1 VIAL, SINGLE-DOSE | INJECTION | 1 | 2 | |
| 63323-751-13 | Phenylephrine Hydrochloride | 25 in 1 CARTON | INJECTION | 25 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63323-751 | PHENYLEPHRINE HYDROCHLORIDE (PHENYLEPHRINE HYDROCHLORIDE) INJECTION [FRESENIUS KABI USA, LLC ] | 7 | Current NDC, Legacy NDC, 2 package rows | 20231208_1e77b9c8-fa17-4aa4-adc8-ff716ab2e5d7.zip |
| 63323-751 | PHENYLEPHRINE HYDROCHLORIDE (PHENYLEPHRINE HYDROCHLORIDE) INJECTION [FRESENIUS KABI USA, LLC ] | 4 | Current NDC, Legacy NDC, 4 package rows | 20240125_c7026b15-1228-4acb-beed-4474fcdbb972.zip |
| 63323-751 | PHENYLEPHRINE HYDROCHLORIDE (PHENYLEPHRINE HYDROCHLORIDE) INJECTION [FRESENIUS KABI USA, LLC ] | 2 | Current NDC, Legacy NDC, 2 package rows | 20240110_f2dce7f1-6538-4747-9792-665eee45c0a9.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63323-751-00 | ML - Milliliter | 63323-751 | 1394c34e-4c42-4094-b1b2-afcdc13e132b | 1 | 2019-07-02 |
| 63323-751-01 | ML - Milliliter | 63323-751 | a8b40ddc-6423-477a-9e40-f4a05b934ade | 1 | 2019-07-02 |
| 63323-751-03 | ML - Milliliter | 63323-751 | cf951bf5-4a25-4cb0-9c6b-c9e4c8cb2180 | 1 | 2020-08-06 |
| 63323-751-05 | ML - Milliliter | 63323-751 | 321cea9d-af97-405d-9cb3-812f3c5e23d3 | 1 | 2019-07-02 |
| 63323-751-10 | ML - Milliliter | 63323-751 | 9610d875-e8cc-4c7b-83b7-8b4ebf6a4e9e | 1 | 2019-07-02 |
| 63323-751-13 | ML - Milliliter | 63323-751 | ec8453b5-99f8-4776-90d2-3d17719905cf | 1 | 2020-08-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sinus Relief MAXIMUM STRENGTH | ACETAMINOPHEN, PHENYLEPHRINE HCL | Better Living Brands, LLC | ccd30132-6e29-48a2-a380-7c14984fc723 | 2026-09-09 | Warnings | 04JA59TNSJ |
| Mucus Relief Severe Congestion and Cough Maximum Strength | DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | Raritan Pharmaceuticals Inc | 8a166067-b492-4742-b74c-28fac87c8d70 | 2026-09-09 | Warnings | 04JA59TNSJ |
| Hemorrhoidal | GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM | Rite Aid Corporation | 407c78ca-6fee-4ed6-b61b-711ec049c86e | 2026-09-09 | Warnings | 04JA59TNSJ |
| Vicks DayQuil VapoCOOL SEVERE COLD and FLU plus CONGESTION | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | The Procter & Gamble Manufacturing Company | efb69cc1-a745-6efc-e053-2a95a90abdc9 | 2026-09-08 | Warnings | 04JA59TNSJ |
| Vicks NyQuil VapoCOOL Severe COLD and FLU plus CONGESTION | ACETAMINOPHEN, PHENYLEPHRINE HYDROCHLORIDE, DOXYLAMINE SUCCINATE, AND DEXTROMETHORPHAN HYDROBROMIDE | The Procter & Gamble Manufacturing Company | efb5f0b9-9825-ab23-e053-2995a90a26ab | 2026-09-08 | Warnings | 04JA59TNSJ |
| Vicks childrens Cough Congestion | PHENYLEPHRINE HCL, DEXTROMETHORPHAN HBR, GUAIFENESIN | The Procter & Gamble Manufacturing Company | e2356457-9791-3710-e053-2995a90ad140 | 2026-09-08 | Warnings | 04JA59TNSJ |
| Nighttime Severe Cold and Cough | ACETAMINOPHEN, DIPHENHYDRAMINE, PHENYLEPHRINE | RARITAN PHARMACEUTICALS INC | 9819155b-2713-42be-867e-16605e7643d0 | 2026-09-08 | Warnings | 04JA59TNSJ |
| Thyroid Support | CALCAREA CARBONICA, CALCAREA IODATA, CAUSTICUM, FERRUM IODATUM, FUCUS VESICULOSUS, KALI IODATUM, NATRUM MURIATICUM, THYROIDINUM (BOVINE) | NaturalCare | 07b4e0ed-2b00-4d0a-ad8f-fc6deff15325 | 2026-09-08 | Warnings | 451W47IQ8X |
| severe cold and cough daytime | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE | RARITAN PHARMACEUTICALS INC | 3ce8508e-7d9d-4413-858a-8f952e760c01 | 2026-09-08 | Warnings | 04JA59TNSJ |
| Multi Symptom Severe Cold | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL | RARITAN PHARMACEUTICALS INC | d9606c9a-31b1-4121-9870-809a05f5b68a | 2026-09-08 | Warnings | 04JA59TNSJ |
| Mucus Relief Severe Congestion and Cough | DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | Chain Drug Marketing Association, Inc. | 2a7afe03-3c34-4e30-827e-b3bb2568cb97 | 2026-09-08 | Warnings | 04JA59TNSJ |
| Daytime Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | KROGER COMPANY | 30d4a6c6-895e-3741-e063-6294a90ab192 | 2026-09-07 | Warnings | 04JA59TNSJ |
| Severe Congestion and Pain | ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HCL | Meijer Distribution, Inc. | 49235f4f-e661-4a83-88ef-b9a956848777 | 2026-09-04 | Warnings | 04JA59TNSJ |
| Psoriasis Control | CENTELLA ASIATICA, SODIUM CHLORIDE, AND SILICON DIOXIDE | Forces of Nature | 2db33771-0bb9-49f8-84fa-dddc28e4ba26 | 2026-09-04 | Warnings | 451W47IQ8X |
| Hemorrhoidal | GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM | CVS Pharmacy | 3167c918-a7d3-46a1-a85b-64f9c22916f2 | 2026-09-04 | Warnings | 04JA59TNSJ |
| Dollar General | NASAL PHENYLEPHRINE HYDROCHLORIDE | DOLGENCORP, INC. (DOLLAR GENERAL & REXALL) | e8fd3f0e-a023-4423-8906-17ae02bc083b | 2026-09-03 | Warnings | 04JA59TNSJ |
| Mucus Relief Congestion and Cough Maximum Strength | DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCI | TARGET Corporation | 1bf9a59e-cc37-4780-ba75-7138c546eb19 | 2026-09-02 | Warnings | 04JA59TNSJ |
| KROGER Saline | NASAL | KROGER COMPANY | c84b242b-f46e-4ea8-a3c1-109a47644646 | 2026-09-02 | Warnings | 451W47IQ8X |
| Childrens Multi Symptom Fever and Cold | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL | THE KROGER CO. | 3daf7620-eb57-43d5-ba88-938b7221e346 | 2026-09-02 | Warnings | 04JA59TNSJ |
| PHENAGIL | PHENYLEPHRINE HCL AND CHLORPHENIRAMINE MALEATE | Gil Pharmaceutical Corp | 69fd13a1-2b76-8574-e053-2a91aa0a27e7 | 2026-09-02 | Warnings | 04JA59TNSJ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.